Rationale: Chitinases are enzymes that cleave chitin, which are present in fungal cells. Two types of human chitinases, chitotriosidase (CHIT1) and acidic mammalian chitinase (AMCase, CHIA), and the chitinase-like protein, YKL-40, appear to play an important role in asthma. We hypothesized that exposure to environmental fungi may modulate the effect of chitinases in asthmatics.
INTRODUCTION
The pathogenesis of asthma, which affects up to 300 million people of all ages in the world and 15 million people in the United States, 1 is mediated by immunological responses which parallel those induced by parasitic infections. Furthermore, fungal exposure appears to be associated with severe asthma and admission to the intensive care unit for asthma. 2, 3 Mammalian chitinases and a chitinase homologue that lacks chitinase activity may contribute to the pathogenesis of type 2 helper (Th2) immune responses and thereby play an important role in asthma. [4] [5] [6] Chitin is a polysaccharide that is present in fungal cells, crustaceans, insects, and parasitic nematodes, and chitinases cleave chitin. [7] [8] [9] Chitin is present in the cell walls of fungi and provide architectural reinforcement to the cell walls; thus exposure to fungi correlates with exposure to chitin. 10 Chitinases appear to play an important role in T-helper 2 (Th2)-mediated inflammation and allergic diseases such as asthma. A study in rats found that intratracheal infection with a fungus, C. neoformans, induces generalized chitinase activity in bronchoalveolar lavage fluid and lung, suggesting a link between respiratory fungal infection and asthma through the induction of chitinase.
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Although chitin does not exist in humans, two chitinases, acidic mammalian chitinase (AMCase, CHIA) and chitotriosidase (CHIT1), have been described in humans. 7 A third protein, chitinase-like protein YKL-40 (also known as human cartilage glycoprotein 39 and chitinase 3-like 1) also appears to play an important role in asthma. 6 These two chitinases perform important defensive functions against chitin-containing pathogenic organisms in both the gastrointestinal tract and lungs. CHIT1 is primarily expressed in the lung, while CHIA is highly expressed in the lungs of patients with asthma, but not in normal subjects. In studies of mice, CHIA appears to play an influence the development of bronchial asthma. 4 Inhibition of CHIA in mice leads to an abrogated T-helper cell type 2 inflammation, reduced bronchial hyperreactivity, and lower eosinophil counts. 4 Studies have also found that chitin may protect mice from asthma. 12 Levels of YKL-40 are higher in patients with asthma than healthy persons, and patients with more severe asthma have higher levels of YKL-40.
Wu, page 4 We have previously reported that variants in CHITI, CHIA, and CHI3L1 are not associated with asthma or asthma-related phenotypes. 13 However, we hypothesized that the effects of these genes may only be increased in the appropriate environmental context, in this case exposure to high levels of house dust fungi.
The objectives of this study were to assess whether fungal exposure modulates the effect of variants in CHIT1, CHIA, and CHI3L1 and one CHIT1 duplication on emergency department visits and hospitalizations from asthma. We hypothesized that exposure to fungi, as a source of environmental chitin exposure, would influence the association of SNPs in the genes of chitinases and chitinase-like protein because these genes have been found to be associated with asthma severity, and fungal exposure is known to be associated with asthma symptoms, and higher fungal levels suggest higher chitin levels. Our secondary objectives were to assess whether fungal exposure modulates the association of these SNPs and changes in lung physiology that are associated with asthma, or allergy-related phenotypes.
METHODS

Study Population
We used data from the Childhood Asthma Management Program (CAMP), a multi-center trial that enrolled children between the ages of five and 12 years with mild to moderate persistent asthma between 1993-1995. 14 We included data from 395 Caucasian subjects and their parents. Subjects were randomly assigned to receive budesonide, nedocromil, or placebo and were followed every two to four months for four years in order to study the long-term use of the medications. Details of this study have been previously published. 14 The institutional review board at each of the eight participating institutions approved the study and parents or guardians of the subjects gave informed consent.
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Measures
Mold measures (an index of fungal exposure) in the home environment were taken by research assistants. Details have been described previously. 14, 15 Briefly, during a study visit, a CAMP-certified of the kitchen floor, and a major item of upholstered furniture to which the child was exposed. Each area was vacuumed for 2 minutes. The specimens were shipped frozen to the Dermatology Allergy Clinical
Immunology Laboratory at Johns Hopkins University, Baltimore, MD, where they were analyzed. An agar plate was streaked for enumeration of mold colonies, and the colonies were not further identified.
The mold colonies were reported in units/gram of house dust. We chose to stratify the mold levels by > or ≤ 25,000 units/gram as used in a previous CAMP study. 15 At each study visit that occurred every four months, subjects reported on the number of hospitalizations and emergency department visits they had experienced since the last study visit.
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Research assistants obtained spirometry measurements on the subjects both before and after a bronchodilator at each study visit. Bronchodilator response (BDR) was calculated at each visit as 
SNP Genotyping
SNPs in CHIT1, CHIA, and CHI3L1 were genotyped, in addition to a CHIT1 duplication which has been previously studied. 17 SNPs in CAMP were genotyped using the Infinium HumanHap550 genotyping at Illumina (San Diego, CA). Genotyping quality was evaluated using the program PLINK (V1.01). SNPs with low Illumina gencall scores, poor completion rates, or four or more parent-offspring genotyped inconsistencies were dropped. Using the Basic Local Alignment Search Tool (BLAST), SNPs were further limited to those whose flanking sequences were reliably mapped to unique autosomal Wu, page 6 locations in the hg17 reference genome sequence. Mitochondrial and sex-linked markers were not included. The CHIT1 fragment analysis was performed utilizing the Applied Biosystems (AB) 3100
Genetic Analyzer platform. Primers CHIT1_A1FGTCTGGATGAGGGGGTATCG-FAM and CHIT1 A1RGTTTCTTCCCTGCACAGGTCAGCTATC were used to PCR amplify the region containing the 24-bp duplication, and peaks were analyzed with AB GeneMapper software. Genotyping completion rate was 94%.
Family-Based Association Test-Generalized Estimating Equations (FBAT-GEE)
FBAT-GEE is a method that has the ability to use genetic data from family members to assess potential associations between a disease phenotype and a gene allele. 18, 19 This methodology has been robust in identifying the associations between SNPs with complex diseases, particularly in genome-wide association studies. We performed association analyses for each SNP and each phenotype using the FBAT-GEE approach which has been described previously. 20 We used Vansteelandt et al.'s method 21 that uses causal inference to derive estimating equations that generate an estimate of the main genetic effect, ß 1 , and the gene-by-environment interaction, ß 2 after accounting for the main genetic effect. The general principle behind FBAT-Interaction is that after removing the overall main genetic effect, the phenotype should not depend on the genotypes conditional on the environmental exposure under the null hypothesis.
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In the analysis for this study, the additive genetic model was used and a minimum of 20 informative families were required. We utilized an FBAT approach with generalized estimating equations (FBAT-GEE) 23 for our outcomes. The main outcome was severe exacerbations defined as one or more hospitalizations or emergency department visits experienced during the four years of the study.
RESULTS
Descriptive Statistics
Our study population included 395 Caucasian subjects, who had available genotype information Wu, page 7 and mold levels. The mean age was 8.7 years [SD 2.1]. Table 1 provides the baseline demographic characteristics measured in our study population. The mean age of the subjects with mold levels of >25,000 units/gram was 8.7 years and 8.8 years for subjects with mold level of ≤25,000 units/gram (p=0.68). Of the subjects with mold level >25,000 units/gram, 33% were in the budesonide group, while 26% of subjects with mold level ≤25,000 units/gram were in the budesonide group; this difference was not statistically significant. A slightly higher percentage of subjects in the group with mold level >25,000 units/gram were male (65% vs 61%, p=0.49). There were no differences between the groups of subjects with mold level >25,000 units/gram and ≤25,000 units/gram with respect to the total number of hospitalization and ED visits over the 4 year period of the trial, pre-FEV 1 , bronchodilator response, FEV 1 percent predicted, lnPC 20 , Log 10 IgE, Log 10 Eosinophil, parental history of asthma or atopy.
FBAT analysis
We studied 395 subjects and their parents, and there was one affected offspring within each family. Table 2 
DISCUSSION
Mold levels may modify the effect of variants in the chitinase gene, CHIT1, on emergency department visits and hospitalizations from asthma. We also found that mold levels do not modify the association between other variants in CHIT1, and variants in both CHIA, and CHI3L1 and childhood asthma or asthma-related phenotypes. To our knowledge, this was the first study to examine the effect of mold levels on the association of SNPs in the genes of both chitinases and chitinase-like proteins with asthma and allergy-related phenotypes. Strengths of our study include the availability of mold levels in a well-defined clinical trial, the availability of outcomes over a 4 year time-period, and a family-based design that avoids issues with population stratification.
Our results support increasing evidence that CHIT1, which is primarily expressed in the lung, plays an important role in the pathophysiology of asthma in the proper environmental context of exposure to chitin, which was approximated by mold levels. 24 Our results are supported by a study of workers in the snow crab-processing industry who are exposed to high levels of chitin, which are found in the exoskeletons of crustaceans, found that cumulative exposure to snow crab allergens is associated with prevalence of occupational asthma and allergy in a dose-response manner, even after adjusting for age, gender, and smoking. 25 Furthermore, intranasal administration of chitin to mice induces the accumulation of interleukin-4 expressing innate immune cells, inducing eosinophils and basophils, 26 further lending support to the notion that exposure to chitin induces an allergic phenotype. Chitinases appear to be able to negatively regulate the tissue infiltration of eosinophils and basophils.
Wu, page 9 activity of chitinases may be protective against development of allergies or asthma by breaking down chitin. Additional evidence supporting our hypothesis is a pilot study which found that subjects with the CHIT1 genotype that correlates with decreased levels of chitotriosidase had increased susceptibility to filarial infection. 27 These findings in the pathophysiology of asthma support our finding that CHIT1 may be associated with hospitalizations and ED visits from asthma in the setting of varying mold exposures. One potential reason for the conflicting findings in the literature is environmental heterogeneity in exposure to sources of chitin between populations, and we show that accounting for environmental exposure to mold levels may help to clarify these genetic associations.
Despite the strengths of our study, a few caveats deserve mention. First, our sample size of 395 subjects was relatively small. Nevertheless, we did find that mold exposure significantly modified the relation between three SNPs in CHIT1 and one or more emergency department visits or hospitalizations from asthma. Secondly, our analysis was limited to one population and we did not have a replication population for study; thus, our results may not be generalizable to other populations. To our knowledge, no other longitudinal clinical trials of asthma have measured mold levels as an exposure; thus we do not have other populations to replicate our findings. A recent review article on gene by environment interaction in asthma mentioned that the study of gene-environment interaction in relation to asthma is in its infancy. 33 Thus, our findings provide support for future studies examining gene-environment interactions in asthma, and should encourage evaluation of environmental exposures in these studies. In Wu, page 10 addition, we only included mold measurement from the randomization visit. Although a second mold measurement was attempted at the 3 year visit, 23% of subjects did not have a mold measurement, and FBAT does not allow repeated measurements for the environment variable. Finally, it is likely that mold exposure is only one source of chitin exposure. A comprehensive evaluation of all sources of environmental chitin exposure was beyond the scope of this study.
Both in vitro and in vivo studies have demonstrated that chitin and chitin derivatives have important immunologic effects and play an important role in pulmonary inflammation. 34 The literature suggesting the importance of chitinases in the pathophysiology of asthma is strong, [4] [5] [6] [7] [8] [9] 12 and chitinases may play a role in future targets for asthma therapy. 24 In future genetic studies of asthma, measurements of fungal levels could contribute important knowledge on the pathophysiology of asthma.
In conclusion, fungal levels may modulate the effect of variants in the chitinase gene, CHIT1, on emergency department visits and hospitalizations. This finding supports the important role that chitinases have in asthma. Wu, page 22 Figure 1 . Linkage disequilibrium (LD) plot for CHIT1 demonstrating that rs2486953, rs4950936, and rs1417149 are in linkage disequilibrium with each other. LD is measured as D', with darker gray colors indicating higher values. The number in each box represents the r 2 between the two corresponding SNPs.
Wu, page 23 Figure 2 . Depiction of the effect of mold level >25,000 units/gram and genotype on the outcome of hospitalizations and emergency department visits for rs2486953. E=1 refers to exposure to a mold level of >25,000 units/gram and E=0 refers to a mold level of ≤ 25,000 units/gram. G stands for genotype and there are 3 possibilities for the number of copies of rs2486953: 0 copies, 1 copy, or 2 copies. Y refers to the probability of having 1 or more hospitalizations and emergency department visits. This figure demonstrates that with exposure to a mold level of >25,000 units/gram, having two copies of the minor allele produces a much higher probability of experiencing effect on hospitalizations and emergency department visits than with no exposure to this mold level. 
